Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)
CUSIP: 19249H103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 153,624,096
- Total 13F shares
- 55,358,578
- Share change
- -6,696,363
- Total reported value
- $40,439,575
- Put/Call ratio
- 34%
- Price per share
- $0.73
- Number of holders
- 109
- Value change
- -$4,928,963
- Number of buys
- 47
- Number of sells
- 52
Quarterly Holders Quick Answers
What is CUSIP 19249H103?
CUSIP 19249H103 identifies CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 19249H103:
Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
11,151,905
|
$8,999,588 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.1%
|
10,978,359
|
$8,859,535 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13D/G
13F
|
Company |
4.6%
|
5,258,754
|
$5,258,754 | $0 | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.3%
|
5,097,362
|
$4,113,571 | — | 31 Mar 2025 | |
| Kohlberg Kravis Roberts & Co. L.P. |
13F
|
Company |
2%
|
3,036,076
|
$2,409,974 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,899,952
|
$2,340,261 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
2,655,500
|
$2,143,452 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
2,226,851
|
$1,797,069 | — | 31 Mar 2025 | |
| CM Management, LLC |
13F
|
Company |
1.4%
|
2,147,500
|
$1,733,033 | — | 31 Mar 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
1.3%
|
1,928,464
|
$1,556,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.67%
|
1,021,881
|
$824,658 | — | 31 Mar 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.65%
|
991,513
|
$800,151 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
950,676
|
$767,196 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.62%
|
947,124
|
$764,330 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.59%
|
899,999
|
$726,000 | — | 31 Mar 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.54%
|
835,000
|
$673,845 | — | 31 Mar 2025 | |
| Tejara Capital Ltd |
13F
|
Company |
0.45%
|
687,218
|
$554,585 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.43%
|
667,965
|
$539,048 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.4%
|
620,588
|
$500,815 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
547,707
|
$442,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
510,628
|
$412,077 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
389,121
|
$314,020 | — | 31 Mar 2025 | |
| Vincent R. Anicetti |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
274,790
mixed-class rows
|
$304,488 | — | 06 Jul 2021 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
368,951
|
$297,744 | — | 31 Mar 2025 | |
| Vladimir Vexler |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
116,361
|
$283,921 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.22%
|
330,693
|
$266,869 | — | 31 Mar 2025 | |
| STRS OHIO |
13F
|
Company |
0.21%
|
324,000
|
$261,468 | — | 31 Mar 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.21%
|
317,625
|
$256,323 | — | 31 Mar 2025 | |
| Tyche Wealth Partners LLC |
13F
|
Company |
0.17%
|
265,766
|
$214,473 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
230,990
|
$186,410 | — | 31 Mar 2025 | |
| McDavid Stilwell |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
145,305
mixed-class rows
|
$183,744 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
223,125
|
$180,062 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
202,948
|
$163,781 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.13%
|
196,927
|
$158,000 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.12%
|
188,410
|
$152,047 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.12%
|
186,721
|
$150,684 | — | 31 Mar 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.1%
|
157,975
|
$127,486 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
148,494
|
$119,824 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
143,000
|
$115,401 | — | 31 Mar 2025 | |
| Paul Reider |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
242,069
mixed-class rows
|
$114,076 | — | 20 Jan 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.08%
|
124,915
|
$100,806 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.08%
|
117,983
|
$95,566 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
106,315
|
$85,796 | — | 31 Mar 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.07%
|
104,987
|
$85,039 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.06%
|
95,056
|
$76,710 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.06%
|
93,719
|
$75,631 | — | 31 Mar 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.05%
|
75,020
|
$60,541 | — | 31 Mar 2025 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.04%
|
69,000
|
$55,683 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
66,713
|
$53,837 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
66,219
|
$53,439 | — | 31 Mar 2025 |
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q2 2025
As of 30 Jun 2025,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,358,578 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Kohlberg Kravis Roberts & Co. L.P., GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, STATE STREET CORP, C WorldWide Group Holding A/S, MILLENNIUM MANAGEMENT LLC, and CITIGROUP INC.
This page lists
110
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
114
Q2 2025 holders
109
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.